AI Article Synopsis

  • The study investigated the effectiveness and safety of oral gabapentin in reducing fear responses in confined community cats during trap-neuter-return (TNR) efforts.
  • Cats were randomly assigned to receive either a placebo, a low dose (50 mg), or a high dose (100 mg) of gabapentin, and their fear levels were assessed over time by a blinded observer.
  • Results showed that both doses of gabapentin significantly lowered fear scores without increasing sedation or causing adverse effects, suggesting it may be beneficial for managing stress in trapped cats.

Article Abstract

Objectives This double-blind, placebo-controlled study evaluated the safety and efficacy of single-dose oral gabapentin administered for the attenuation of fear responses in cage-trap confined community cats. Methods Community cats presented in cage traps for trap-neuter-return (TNR) were recruited and screened for inclusion. Each enrolled cat was randomly assigned and administered one of three equal-volume, single-dose treatments: placebo, low-dose gabapentin (50 mg) or high-dose gabapentin (100 mg). At baseline, 1, 2, 3 and 12 h post-administration, a single, blinded observer scored each cat for signs of fear and sedation using published paradigms, calculated the respiratory rate and documented any observable facial injuries. Results Fifty-three cats met the inclusion criteria and completed the study. Cat stress score (a measure of fear) was lower in cats that received gabapentin (50 or 100 mg) than in cats that received placebo (50 mg: P = 0.027; 100 mg: P = 0.029), with the greatest reduction at 2 h post-treatment ( P = 0.0007). Respiratory rates did not differ between treatment groups. There was no difference in sedation scores between the groups ( P = 0.86) at any time point ( P = 0.09). Cat facial injuries did not vary by treatment group or over time. No adverse effects were detected specific to gabapentin administration. At 1 h, hypersalivation was observed in four cats across all treatment groups. All cats recovered from surgery and anesthesia uneventfully. Conclusions and relevance This study supports the hypothesis that 50 mg or 100 mg gabapentin (9.2-47.6 mg/kg per cat) reduces fear responses in confined community cats without measurable sedation over 3 h post-administration vs placebo. Gabapentin treatment was well tolerated in this population of cats. Further studies are recommended to investigate the use of oral gabapentin earlier in the TNR process, such as immediately after trapping or prior to transport for the prevention of confinement-related injuries.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11104070PMC
http://dx.doi.org/10.1177/1098612X17719399DOI Listing

Publication Analysis

Top Keywords

community cats
16
oral gabapentin
12
fear responses
12
confined community
12
cats
10
gabapentin
9
single-dose oral
8
responses cage-trap
8
cage-trap confined
8
double-blind placebo-controlled
8

Similar Publications

Clinical Manifestations.

Alzheimers Dement

December 2024

Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.

Background: The Visual Cognitive Assessment Test (VCAT) is a visual based, language neutral cognitive assessment validated across cultures and ethnicities, that allows for early diagnosis of cognitive impairment. The VCAT assess domains of cognition - Memory, Visuospatial function, attention, language and Executive function. The Mild Behavioural Impairment Checklist (MBI-C) was developed to assess five domains of NPS - Decreased motivation, emotional dysregulation, impulse control, social inappropriateness and abnormal beliefs/perceptions Current research indicates an association between MBI symptom severity and poorer cognitive performance in the domains of memory.

View Article and Find Full Text PDF

NDM-5-plasmid diversity in multiple international high-risk Escherichia coli clones associated with canine and feline extraintestinal infections.

Vet Microbiol

December 2024

Division of Molecular Bacterial Epidemiology and Infectious Diseases, Institute of Veterinary Bacteriology, Vetsuisse Faculty, University of Bern, Länggassstrasse 122, CH-3012 Bern, Switzerland. Electronic address:

NDM-5-producing Escherichia coli are the predominant carbapenemase producers of medical and public health importance. The global spread of bla-containing plasmids in high-risk E. coli clones has been primarily documented in humans and increasingly reported in animals and the environment.

View Article and Find Full Text PDF

Background: Antimicrobial resistance (AMR) is a global health concern that is exacerbated by the transmission of bacteria and genetic material between humans, animals and the environment. This study investigated AMR of Escherichia coli (E. coli) isolated from cats' feces and their drinking water.

View Article and Find Full Text PDF

Animal shelters address animal welfare in communities through the intake and outcome of companion animals, but these efforts affect population dynamics of companion animals based on the distance animals are moved and the factors that underlie intake and outcome. Using data from an animal shelter in Washington, DC we analyzed cat intakes and outcomes based on geographic and socioeconomic factors. Most intakes were stray cats (59%) and cats relinquished by owners (38%) and most outcomes were adoptions (84%).

View Article and Find Full Text PDF

Assessing the pathogenicity of a disease-associated genetic variant in animals accurately is vital, both on a population and individual scale. At the population level, breeding decisions based on invalid DNA tests can lead to the incorrect inclusion or exclusion of animals and compromise the long-term health of a population, and at the level of the individual animal, lead to incorrect treatment and even life-ending decisions. Criteria to determine pathogenicity are not standardized, i.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!